AlphaYouIOVA: Berkowitz Noah discloses securities transactions
By AlphaYouPublished Form 4
Berkowitz Noah
Reporting filer
Berkowitz Noah reported Grant or award in IOVANCE BIOTHERAPEUTICS, INC.: 135000 units of Stock Options (Right to Buy) (derivative), dated 2026-09-30. The full Form 4 contains 3 transaction entries.
- Disclosed
- Oct 2, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) (derivative) | Berkowitz Noah | 2026-09-30 | A | Grant or award | 135000 | 0.00 | 135,000 | 2 days | Filed terms
|
| Restricted Stock Units (derivative) | Berkowitz Noah | 2026-09-30 | A | Grant or award | 180000 | 0.00 | 180,000 | 2 days | Filed terms
|
| Performance Stock Units (derivative) | Berkowitz Noah | 2026-09-30 | A | Grant or award | 135000 | 0.00 | 135,000 | 2 days | Filed terms
|
Stock Options (Right to Buy) (derivative)
- Owner
- Berkowitz Noah
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 135000
- Price
- 0.00
- Following holdings
- 135,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Options (Right to Buy)
- conversion Or Exercise Price: 14.82
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 135000
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-09-30
- underlying Security Title: Common stock
- underlying Security Shares: 135000
- shares Owned Following Transaction: 135000
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Berkowitz Noah
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 180000
- Price
- 0.00
- Following holdings
- 180,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F2
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 180000
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F1
- id: F1
- underlying Security Title: Common stock
- underlying Security Shares: 180000
- shares Owned Following Transaction: 180000
- direct Or Indirect Ownership: D
Performance Stock Units (derivative)
- Owner
- Berkowitz Noah
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 135000
- Price
- 0.00
- Following holdings
- 135,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Performance Stock Units
- id: F3
- transaction Date: 2026-09-30
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 135000
- id: F4
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F5
- id: F5
- underlying Security Title: Common stock
- underlying Security Shares: 135000
- shares Owned Following Transaction: 135000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Berkowitz Noah: Chief Medical Officer.
- F1: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
- F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3: Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.
- F4: Up to 135,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain regulatory milestones.
- F5: Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones.
Original sources
Prepared automatically from public filing data. Report a correction.